Near point-of-care adoption of Cepheid Xpert® Flu/RSV XC testing within an integrated healthcare delivery network

Diana R. Hernandez, Grant P. Pellitteri, Donna J. Kimmich, Barbara J. Heiter, Ken Smeal, Donna Wolk

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Flu/RSV testing was implemented in out-patient clinic-based physician office laboratories throughout Pennsylvania. On-site testing reduced the collect-to-result time by 70% when compared to testing in a centralized core laboratory; over- or under-treatment for influenza A and B (measured by anti-viral prescription) was reduced by 15% (P < 0.0001). Antimicrobial prescription was not affected by on-site testing.

Original languageEnglish (US)
JournalDiagnostic Microbiology and Infectious Disease
DOIs
StateAccepted/In press - Jan 1 2018
Externally publishedYes

Keywords

  • Flu
  • Flu test
  • Point-of-care
  • RSV

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Near point-of-care adoption of Cepheid Xpert® Flu/RSV XC testing within an integrated healthcare delivery network'. Together they form a unique fingerprint.

  • Cite this